Guardant Health (GH) shares soared 26% amid heavy trading after the company reported overnight improved Q3 financial results and lifted its 2025 revenue outlook.

More than 6.4 million shares traded intraday compared with a daily average of about 2.6 million.

Novo Nordisk (NVO) said Thursday it submitted an unsolicited proposal to acquire Metsera (MTSR) for $56.50 per share, for an aggregated equity value of about $6.5 billion or an enterprise value of around $6.0 billion.

In a separate statement, Metsera said Novo Nordisk's proposal constitutes a "superior company proposal" to Pfizer's (PFE) bid, which is valued at $7.3 billion, including milestones.

Metsera shares soared 25% as intraday trading volume advanced to more than 6.7 million from a daily average of about 2.04 million.

Indivior (INDV) reported Q3 adjusted earnings and revenue that grew from a year ago, and the company also raised its 2025 revenue guidance.

Shares jumped 15%, with intraday trading volume at 7.7 million compared with a daily average of about 2.5 million.

Price: 92.34, Change: +20.07, Percent Change: +27.76